TELO (Telomir Pharmaceuticals) Short-Term Debt to Capital

Corporate company logo of Telomir Pharmaceuticals (TELO)

This daily price chart for Telomir Pharmaceuticals (TELO) reflects metrics at the level of 0.03. The business leverages AI and robotics to accelerate the identification of anti-aging compounds. Telomir Pharmaceuticals (TELO) is currently in an active development stage for agents that increase telomere length to ensure longevity. The creation of innovative drugs for age-related ailments guarantees long-term demand for the company's patented solutions.

Ratio of Short-Term Indebtedness to Capital: Telomir Pharma (TELO) for 02/21/2024 - 11/01/2026

Analytical breakdowns for Telomir Pharmaceuticals

- stock quotes and analyst forecast:
Stock Price Telomir Pharma|TELO - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Telomir Pharmaceuticals Inc|TELO - Enterprise Value
- book capitalization information:
Net Assets per Single Share Telomir Pharmaceuticals|TELO - Accounting Value of Company|Market Value to Book Value Ratio telomirpharma.com|TELO - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Telomir Pharmaceuticals|TELO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Telomir Pharmaceuticals, Inc.|TELO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Telomir Pharmaceuticals Inc|TELO - Long-Term Debt|Company Current Liabilities Telomir Pharmaceuticals|Quick Ratio telomirpharma.com
- company profitability and valuation multiples indicators:
TELO - Final Profit
Fundamental valuation:TELO Telomir Pharma
Brand item of Telomir Pharmaceuticals Inc

This indicator is critical for liquidity stress testing, as it allows for an assessment of the company's reliance on urgent borrowed capital relative to its net assets. By analyzing the short-term liabilities-to-capital chart, an investor can see the actual debt load of Telomir Pharmaceuticals (TELO), which remains low due to the outsourcing of production to CDMO plants and the absence of costs associated with maintaining its own facilities.

Competitors of Telomir Pharmaceuticals (TELO)

Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|BioHarvest Sciences Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio EXOZ (Invizyne Technologies)|Oramed Pharma - Short-Term Debt to Capital|Current Liabilities to Capital Entera Bio Ltd.|MindWalk Holdings (HYFT) - Short-Term Debt to Equity|ABVC (abvcpharma.com) - Short-Term Debt to Equity|Short-Term Debt to Equity Cumberland Pharmaceuticals Inc.|Current Liabilities to Capital Quantum BioPharma Ltd. QNTM|Short-Term Debt to Equity FibroGen Corp (FGEN)|Short-Term Debt to Equity Ratio ranitherapeutics.com RANI|Short-Term Debt to Capital SNYR (Synergy CHC)|Short-Term Debt to Capital Coefficient Rallybio Corp (RLYB)|LEXX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital PULM (Pulmatrix Inc)|PTHL (ftzy.com.cn) - Short-Term Debt to Equity Ratio|Aptorum Group - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Lyra Therapeutics, Inc.|impactbiomedinc.com - Current Liabilities to Equity|Short-Term Debt to Capital TNFA|YCBD (cbdmd.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital PRFX (PainReform Limited)|Short-Term Debt to Capital Altamira Therapeutics Ltd CYTO|LIPO - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital OPTN (optinose.com)|Pieris Pharmaceuticals, Inc. (PIRS) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Procaps Group|PTPI (Petros) - Short-Term Debt to Capital|Short-Term Debt to Capital Qilian International Corp|Short-Term Debt to Capital SLRN|Short-Term Debt to Equity Ratio tffpharma.com TFFP